Study to Predict the Benefits of First-line Humidification Use and Comparison of the Effect of ThermoSmart™ and no Humidification on Adherence

NCT ID: NCT01742949

Last Updated: 2019-05-07

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-10-31

Study Completion Date

2014-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to investigate the benefits of using first line heated humidification. The primary objective of this research is to determine the effect of high levels of humidification delivered by ThermoSmart™ on CPAP adherence. In addition, to determine if it is possible to predict which patients benefit the most (i.e. be more adherent with therapy) from high levels of humidification delivered by ThermoSmart.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obstructive Sleep Apnea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Thermosmart

Subjects receive heated humidification

Group Type ACTIVE_COMPARATOR

Heated humidification (ThermoSmart)

Intervention Type DEVICE

Heated Humidification (ThermoSmart) Turned On

No humidification

Subjects use dry CPAP / APAP

Group Type PLACEBO_COMPARATOR

No Humidification

Intervention Type DEVICE

Heated Humidification (ThermoSmart) Turn Off

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Heated humidification (ThermoSmart)

Heated Humidification (ThermoSmart) Turned On

Intervention Type DEVICE

No Humidification

Heated Humidification (ThermoSmart) Turn Off

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Older than 18 years of age
* Diagnosed with OSA and eligible for CPAP treatment under local requirements (AHI\>30 or if AHI is lower than 30, at least 10 micro arousals identified during diagnosis PSG).
* Naïve to CPAP therapy, i.e have not been prescribed, or used CPAP in the last 5 years
* Patients receiving social security coverage (excluding MEAs)
* Fluent spoken and written French

Exclusion Criteria

* Severe heart disease
* Co-existing lung disease
* Co-existing sleep disorder
* Pregnant
* Refused participation
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fisher and Paykel Healthcare

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marie-Pia D'Dortho, MD

Role: PRINCIPAL_INVESTIGATOR

Hôpital Bichat-Claude Bernard

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital Bichat-Claude Bernard

Paris, Paris Cedex, France

Site Status

Hôpital Henri Mondor

Paris, , France

Site Status

Hôpital La Pitie Salpetriere

Paris, , France

Site Status

Hôpital Louis Mourier

Paris, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FPH-TS2012

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Post-Market BTVA Registry
NCT03318406 RECRUITING
STIMIT Activator 1 IDE Study
NCT05883163 RECRUITING NA
CPAP in Liver Transplant
NCT00510770 UNKNOWN PHASE4